Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611022 · ClinicalTrials.gov registry record · NA
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
A NA study of Human Papilloma Virus, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT04611022: Recruiting NA study of Human Papilloma Virus, sponsored by University of Colorado, Denver.
NCT04611022 is a NA study of Human Papilloma Virus that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 1,000 participants, below the 8,416-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04611022, a NA study of Human Papilloma Virus, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist of Power Point presentations, flyers, and posters that contain information about HPV(Human Papilloma Virus), HPV-related cancers, and the importance of the HPV vaccine series for adolescents (9-17 years old) and young adults (18-26 year old) who are eligible for the vaccine.
Primary Outcome
Behavioral factors precede uptake of preventive vaccines. Measured by survey post watching HPV video.
Conditions Studied
Interventions
- BEHAVIORAL HPV Educational Intervention
Study Locations (1)
Colorado
- University of Colorado Hospital - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-08-28 |
| Est. Completion | 2028-02-01 |
| Phase | NA |
What NCT04611022 shows while recruiting
NCT04611022 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 8,416-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 1 intervention - of which HPV Educational Intervention is the first listed.
NCT04611022 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04611022 about?
NCT04611022 is a clinical study titled "Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine". The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist...
What is the current status of trial NCT04611022?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2020-08-28. Estimated completion is 2028-02-01.
What conditions does trial NCT04611022 study?
This clinical trial studies the following conditions: Human Papilloma Virus.
What interventions are being tested in trial NCT04611022?
The interventions under investigation include: HPV Educational Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04611022?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04611022 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04611022's enrollment target sits among peer trials
1,000 7th of 39 higher than 31 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Impact of Financial Incentives
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI